Ruibang Luo

Institutionthe University of Hong Kong
AddressHong Kong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 1 publications in January 2021 and April 2021 and May 2021 and July 2021 and December 2021
    All Publications
    Bar chart showing 35 publications over 11 distinct years, with a maximum of 7 publications in 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhang Z, Guo L, Huang L, Zhang C, Luo R, Zeng L, Liang H, Li Q, Lu X, Wang X, Ma CY, Shao J, Luo W, Li L, Liu L, Li Z, Zhou X, Zhang X, Liu J, Yang J, Kwan KY, Liu W, Xu Y, Jiang H, Liu H, Du H, Wu Y, Yu G, Chen J, Wu J, Zhang J, Liao C, Chen HJ, Chen Z, Tse HF, Xia H, Lian Q. Distinct Disease Severity Between Children and Older Adults With Coronavirus Disease 2019 (COVID-19): Impacts of ACE2 Expression, Distribution, and Lung Progenitor Cells. Clin Infect Dis. 2021 12 06; 73(11):e4154-e4165. PMID: 33388749.
      Citations: 12     Fields:    Translation:HumansCells
    2. Su J, Wu Y, Ting HF, Lam TW, Luo R. RENET2: high-performance full-text gene-disease relation extraction with iterative training data expansion. NAR Genom Bioinform. 2021 Sep; 3(3):lqab062. PMID: 34235433.
      Citations:    
    3. Yan VKC, Li X, Ye X, Ou M, Luo R, Zhang Q, Tang B, Cowling BJ, Hung I, Siu CW, Wong ICK, Cheng RCK, Chan EW. Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach. Adv Ther (Weinh). 2021 May 20; 2100055. PMID: 34179346.
      Citations: 1     
    4. Luo R, Delaunay-Moisan A, Timmis K, Danchin A. SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done. Environ Microbiol. 2021 05; 23(5):2339-2363. PMID: 33769683.
      Citations: 3     Fields:    Translation:Humans
    5. Zhang Z, Guo L, Lu X, Zhang C, Huang L, Wang X, Duan F, Liang H, Chen P, Zeng L, Shao J, Li H, Li L, Liu L, Li C, Zhang J, Ma CY, Kwan KY, Liu W, Xu Y, Gu X, Jiang H, Du H, Zhang T, Wu Y, Yu G, Chen J, Luo R, Liao C, Tse HF, Chen Z, Chen HJ, Xia H, Lian Q. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19. Theranostics. 2021; 11(5):2170-2181. PMID: 33500718.
      Citations: 6     Fields:    Translation:HumansCells